Form 4: IGM Biosciences Director Christina Teng Topsoe Reports Acquisition of Common Stock

Director Christina Teng Topsoe reports acquisition of IGM Biosciences common stock through restricted stock units and indirect holdings.

Summary

• Christina Teng Topsoe, a director of IGM Biosciences, reported changes in beneficial ownership of the company's common stock on March 29, 2024.
• She acquired 2,687 shares of common stock through fully vested restricted stock units (RSUs) at a price of $0, representing a quarterly retainer payment.
• Topsoe also has indirect ownership of 10,400,564 shares through Topsoe Holding A/S and 9,800 shares through Pillarcater LLC.
• The RSUs will be delivered upon a change in control of IGM Biosciences or Topsoe's retirement/separation from service.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.

Key Dates